Introduction
Eli Lilly has made a significant move in the pharmaceutical industry by launching LillyPod, its own NVIDIA DGX SuperPOD, which is the first of its kind owned and operated by a pharma company. This advancement represents a dedicated compute layer for drug discovery that could unsettle competitors still relying on cloud computing.
When the Chatbot Stops Talking and Starts Drawing
Claude has always been known for its thoughtful writing. But as of March 12th, 2026, Claude has expanded its capabilities to generate charts, diagrams, and other visualizations directly within conversations. According to The Verge, these visuals are not static images but interactive elements that users can engage with. For instance, asking Claude about the periodic table now yields a clickable version where users can explore individual elements.
What Claude Is Actually Doing Here
Claude can generate visuals either proactively or upon request. This dual capability allows Claude to decide when a visual aid would enhance the conversation, providing inline output rather than relying on separate tools for graphical representation. One example provided by Anthropic illustrates this point, as Claude visually demonstrates building weight distribution, making structural reasoning accessible in a way that traditional text cannot achieve. This feature relies on the current model without needing a new release, indicating it’s a capability enhancement rather than a model upgrade.
The Interaction Design Problem Everyone Is Ignoring
Most AI assistants that generate visuals often do so ineffectively. They might create unsolicited charts or require specific prompts that make the process tedious. Anthropic’s contextual approach is more challenging to implement correctly. The key lies in determining when to generate a visual without overwhelming the user with unnecessary graphics. The success of this feature will depend on the model's ability to make sound judgment calls in real-time.
Who This Actually Changes Things For
This update is particularly beneficial for non-technical users—consultants, teachers, and product managers—who may not have the coding skills to create their own visualizations. By providing these users with the ability to produce presentation-ready visuals on demand, Claude enhances its value in professional settings. Anthropic is clearly targeting enterprise applications, suggesting a strong pitch for Claude as an all-in-one tool for various workflows.
The Feature That's Late and Still Welcome
While Claude isn't the first AI assistant to offer chart generation, its precision and reliability in technical explanations set it apart. The real test will be how well the contextual trigger operates in real-world scenarios. If Claude can accurately determine when a visual is warranted, it will significantly enhance user experience. However, if it misinterprets the context too frequently, it could undermine its usefulness.
Key Tools Worth Knowing
- Ink: This tool allows AI agents to deploy full-stack apps autonomously. It auto-detects frameworks, builds apps, and returns live URLs without human intervention. Ideal for those running autonomous coding pipelines.
- Lemonade v10: A local LLM runtime that now supports AMD NPUs on Linux, adding multimodal capabilities. This tool is beneficial for those needing local inference on Linux systems.
Conclusion
Lilly’s launch of the LillyPod supercomputer marks a pivotal moment in drug discovery, pushing competitors to rethink their strategies. Meanwhile, Claude’s new features for generating inline visualizations showcase the growing importance of contextual understanding in AI interactions. Both developments signal an exciting future for their respective fields.
This analysis was originally published in triggerAll — a free daily AI newsletter. Research assisted by AI, reviewed and approved by a human editor. Subscribe at https://newsletter.triggerall.com
I also build custom AI automation systems for businesses. Learn more at https://triggerall.com
Read the full issue → https://newsletter.triggerall.com/p/lilly-s-supercomputer-revolutionizes-drug-discovery
Top comments (0)